As we step into Juvenile Arthritis Awareness Month this July, it’s crucial to shine a light on a condition that affects the lives of many children and teenagers worldwide. Juvenile arthritis, also known as juvenile idiopathic arthritis (JIA), is not a single disease but rather a term used to describe a group of autoimmune and inflammatory conditions that can develop in children under the age of 16.
Many believe that arthritis can only impact older adults. However, juvenile arthritis affects approximately 300,000 children in the United States alone, making it one of the most common childhood diseases. Despite its prevalence, there is still a lack of awareness and understanding about this condition. Juvenile arthritis can manifest in various forms, each with its own set of symptoms, but the common thread among all types is inflammation in the joints, causing pain, swelling, stiffness, and potentially affecting mobility.
Children Affected in United States
Oligoarthritis
This is the most common form, affecting fewer than five joints. It often starts in the knee, ankle, or wrist.
Polyarthritis
Involves more than five joints and can affect both small and large joints. It may resemble adult rheumatoid arthritis.
Enthesitis-Related Arthritis
Characterized by arthritis with intermittent fever and rash. It can also affect internal organs.
Enthesitis-Related Arthritis
Characterized by arthritis with intermittent fever and rash. It can also affect internal organs.
Psoriatic Arthritis
Affects some children with psoriasis, causing joint inflammation, nail changes, and skin lesions.
Living with juvenile arthritis can be challenging for both children and their families. The symptoms can vary from mild to severe, and they may fluctuate over time. Chronic pain and stiffness can interfere with daily activities, school attendance, and social interactions. Managing the condition often requires a multidisciplinary approach involving pediatric rheumatologists, physical therapists, and other healthcare professionals.
While there is currently no cure for juvenile arthritis, early diagnosis and appropriate treatment can help manage symptoms, prevent joint damage, and improve quality of life. Treatment plans may include:
Nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), and in some cases, biologic agents.
Exercises and techniques to improve joint function, strength, and mobility.
Techniques to help children participate in everyday activities more easily.
Including diet modifications and the use of assistive devices as needed.
There are many ways to show support during Juvenile Arthritis Awareness Month:
Together, we can make a difference in the lives of children living with juvenile arthritis. Let’s spread awareness, support research, and advocate for better treatments and ultimately, a cure. Join us in raising awareness this Juvenile Arthritis Awareness Month and beyond.
EN 
SW 
PT 
ES 
HR 
VI